Five-Year Relative Survival 59.6 Percent in Lower-Risk Myelodysplastic Syndromes

WEDNESDAY, Nov. 23, 2022 -- About 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the British Journal of Haematology. Krzysztof M ądry, M.D.,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news